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ABSTRACT 18 
The glycocalyx is a dense layer of carbohydrate chains involved in numerous and fundamental 19 
biological processes such as cellular and tissue homeostasis, inflammation and disease 20 
development. Composed of membrane-bound glycoproteins, sulfated proteoglycans and 21 
glycosaminoglycan side-chains, this structure is particularly essential for blood vascular barrier 22 
functions and leukocyte diapedesis. Interestingly, whilst the glycocalyx of blood vascular 23 
endothelium has been extensively studied, little is known about the composition and function 24 
of this glycan layer present on tissue-associated lymphatic vessels (LVs). Here, we applied 25 
confocal microscopy to characterize the composition of endothelial glycocalyx of initial 26 
lymphatic capillaries in murine cremaster muscles during homeostatic and inflamed conditions 27 
using an anti-heparan sulfate (HS) antibody and a panel of lectins recognising different glycan 28 
moieties of the glycocalyx. Our data show the presence of HS, α-D-galactosyl moieties, α2,3-29 
linked sialic acids and, to a lesser extent, N-Acetylglucosamine moieties. A similar expression 30 
profile was also observed for LVs of mouse and human skins. Interestingly, inflammation of 31 
mouse cremaster tissues or ear skin as induced by TNF-stimulation induced a rapid (within 32 
16hrs) remodelling of the LV glycocalyx, as observed by reduced expression of HS and 33 
galactosyl moieties, whilst levels of α2,3-linked sialic acids remains unchanged. Furthermore, 34 
whilst this response was associated with neutrophil recruitment from the blood circulation and 35 
their migration into tissue-associated LVs, specific neutrophil depletion did not impact LV 36 
glycocalyx remodelling. Mechanistically, treatment with a non-anticoagulant heparanase 37 
inhibitor suppressed LV HS degradation without impacting neutrophil migration into LVs. 38 
Interestingly however, inhibition of glycocalyx degradation reduced the capacity of initial LVs 39 
to drain interstitial fluid during acute inflammation. Collectively, our data suggest that rapid 40 
remodelling of endothelial glycocalyx of tissue-associated LVs supports drainage of fluid and 41 
macromolecules but has no role in regulating neutrophil trafficking out of inflamed tissues via 42 
initial LVs. 43 
  44 
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INTRODUCTION 45 
The glycocalyx is a carbohydrate-enriched layer surrounding all mammalian cells that is 46 
implicated in many biological and pathophysiological responses. In vivo, the glycocalyx of 47 
blood capillaries, the most studied cell surface glycan layer, spans between several hundred 48 
nanometres to a few micrometres on the luminal side, proportional to the size of vessels (Vink 49 
and Duling, 1996;van Haaren et al., 2003;Megens et al., 2007). Biochemically, this glycocalyx 50 
is composed of chains of carbohydrate residues attached to transmembrane glycoproteins, 51 
sulfated proteoglycans and to glycosaminoglycan (GAG) side chains. Among the glycoproteins 52 
forming the glycocalyx of blood vessels are cell adhesion molecules of short molecular length 53 
such as intercellular adhesion molecules (e.g. ICAM-1/2 & VCAM-1) and selectins (Reitsma 54 
et al., 2007). Proteoglycans on the other hand are considered to be the “backbone” molecules 55 
of the glycocalyx (Reitsma et al., 2007) and are either anchored to the cell membrane 56 
(syndecans, glypicans) or secreted into the glycocalyx structure (mimecans, perlecans and 57 
biglycans). GAG side chains are bound to these proteoglycans and are comprised of heparan 58 
sulfate (HS), chondroitin sulfate (CS), and hyaluronan (HA), with HS being the most abundant 59 
in the endothelial glycocalyx (Oohira et al., 1983). GAGs are involved in numerous 60 
homeostatic and pathological functions of blood vessels through their interactions with a 61 
variety of proteins within the lumen of blood vessels. Indeed, the blood vascular endothelial 62 
cell (BEC) glycocalyx forms an integral part of the vascular barrier between flowing blood and 63 
the interstitium. As such, BEC glycocalyx plays a critical role in vascular permeability and the 64 
modulation of inflammatory processes (Tarbell et al., 2005;Reitsma et al., 2007;Wang, 2007). 65 
Specifically, the blood vascular glycocalyx acts as a mechano-transducer of sheer stress forces 66 
from the blood flow and induces the release of nitric oxide to regulate vascular tone (Kolarova 67 
et al., 2014). Furthermore, the sulfated GAG side-chains and the high density of glycans also 68 
provide strong negative electrostatic charges along the luminal surface of BECs that repulse 69 
red blood cells from the endothelium and restrict the diffusion of plasma proteins and solutes 70 
through the vessel wall into the interstitium. In contrast, thinning of BEC glycocalyx is strongly 71 
associated with increased vascular permeability and oedema formation (van den Berg et al., 72 
2003;Chelazzi et al., 2015). 73 
The blood vascular glycocalyx is also intimately associated with the initial steps of leukocyte 74 
recruitment. Specifically, The BEC glycocalyx promotes the interaction between the 75 
leukocyte-expressed adhesion molecule L-selectin with its glycosylated receptor PSGL-1 on 76 
the luminal side of the endothelium. This interaction allows leukocyte integrins to access 77 
endothelial cell adhesion molecules such as ICAM-1 and VCAM-1 during the rolling and 78 
adhesion stages of the recruitment cascade, respectively (Wang et al., 2005). Furthermore, the 79 
glycocalyx GAG side chains are known to bind, and to immobilise, leukocyte pro-80 
inflammatory chemoattractants, in particular the neutrophil chemokines CXCL1 & CXCL2 81 
(Proudfoot, 2006). The latter promotes the transition from rolling to firm adhesion and supports 82 
directional crawling of neutrophils onto the luminal aspect of blood vessels. Similarly, HS 83 
chains present on high endothelial venules control CCL21 chemokine presentation during the 84 
recruitment of naïve lymphocytes and DCs to lymph nodes (Bao et al., 2010). Paradoxically, 85 
inflammation can modify the structure and function of blood vessel glycocalyx; and many cells 86 
including leukocytes and endothelial cells can release proteolytic enzymes and reactive 87 
oxygen/nitrogen species that degrade or modify the BEC glycocalyx. This phenomenon is 88 
particularly important for leukocyte recruitment as most of the adhesion molecules involved in 89 
neutrophil-EC interactions protrude less than 40 nm from the cell membrane whilst the 90 
thickness of the BEC glycocalyx is around 500nm (Sundd et al., 2011). Studies have 91 
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demonstrated that inflammatory mediators such as TNF or lipopolysaccharide (LPS) can 92 
reduce the thickness of BEC glycocalyx by at least a third (Henry and Duling, 2000;Schmidt 93 
et al., 2012;Wiesinger et al., 2013;Marki et al., 2015), allowing leukocyte-expressed adhesion 94 
molecules to reach their binding partners on the BEC surface. 95 
In sharp contrast, the characteristics and role of the glycocalyx on lymphatic vessels (LVs) 96 
have received little attention to date. The lymphatic vasculature is the second circulatory 97 
system of high vertebrates involved in tissue homeostasis, transport of interstitial fluid and 98 
macromolecules back into the blood circulation. The lymphatic system is characterized by a 99 
unidirectional network of vessels starting in most tissues with blind-end vessels also known as 100 
initial LVs or lymphatic capillaries. Initial LVs are composed of monolayer of oak leaf-shaped 101 
endothelial cells (LECs) with loose junctions and surrounded by a thin and discontinuous 102 
basement membrane (Baluk et al., 2007). Those unique vessels drain into pre-collecting 103 
vessels, subsequently merging into large collectors and then afferent lymphatic venules that are 104 
connected to lymph nodes. Lymphatic vessels are thus crucial for immune surveillance as they 105 
contribute to the transport of antigens and trafficking of antigen-presenting cells from tissues 106 
to draining lymph nodes (dLNs). The latter provides a vital means through which adaptive 107 
immune responses are initiated during infections and vaccinations. Recently, the presence of a 108 
glycocalyx layer on the luminal side of large collecting lymphatic vessels in the rat mesentery 109 
was reported by electron microscopy on isolated vessels (Zolla et al., 2015). It was proposed 110 
that the structure and composition of the glycocalyx of collecting LVs and BEC might be 111 
similar. Overall, LEC glycocalyx is believed to establish cytokine/chemokine gradients within 112 
the vessels, an effect that can aid lymphocyte rolling, maintain the homeostatic balance of the 113 
tissues, and contribute to pathogen clearance (Reitsma et al., 2007;Levick and Michel, 114 
2010;Zolla et al., 2015). Interestingly, lymphatic vessels express a unique receptor for the 115 
glycosaminoglycan hyaluronan, known as lymphatic vessel endothelial hyaluronan receptor 1 116 
or LYVE-1 (Banerji et al., 1999). Recently, LYVE-1 has been demonstrated to serve as a 117 
docking molecule for transmigrating dendritic cells and macrophages by binding to HA present 118 
on the surface of these leukocytes (Jackson, 2018;2019). Despite these seminal but limited 119 
studies, there is to date insufficient insight into the exact composition of the glycocalyx of 120 
tissue-associated lymphatic capillaries in vivo. Moreover, little is known about the putative 121 
modifications and role of this LEC glycan layer during inflammation. To address this 122 
fundamental issue, we aimed to characterize the composition, remodelling and function of the 123 
glycocalyx of initial LVs of tissues in steady-state and inflamed conditions. This was achieved 124 
through analysis by confocal microscopy of the lymphatic vasculature in whole-mount murine 125 
cremaster muscles and ear dorsal skin as well as in human skin sections using several lectins 126 
(carbohydrate-binding proteins known to bind specific carbohydrate residues) and/or 127 
antibodies against HS and HA. We found that in vivo, the LV glycocalyx exhibited similarities 128 
with the glycocalyx of post-capillary venules with HS, α-D-galactosyl moieties, α2,3-linked 129 
sialic acids and N-acetylglucosamine chains being present. Interestingly, acute inflammation 130 
as induced by antigen-sensitisation or TNF-stimulation resulted in the rapid remodelling of the 131 
LV glycocalyx as observed by reduced detection of HS and α-D-galactosyl moieties but not of 132 
sialic acids, a response associated with the migration of neutrophils into the lymphatic 133 
vasculature. Mechanistically, we observed that pharmacological blockade of endogenous 134 
heparanase inhibited TNF-induced HS cleavage. This inhibition of glycocalyx remodelling was 135 
associated with a reduced capacity of initial lymphatic capillaries to remove fluids out of the 136 
inflamed interstitium whilst neutrophil interactions with LVs were not affected. Collectively, 137 
our findings present a novel paradigm for the role and function of initial lymphatic glycocalyx, 138 
and demonstrate that its remodelling is important for the rapid drainage of inflamed tissues but 139 
not neutrophil recruitment to the lymphatic system in vivo.  140 
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MATERIALS & METHODS 141 
Reagents 142 
Recombinant murine TNF was purchased from R&D Systems (Abingdon, UK), Complete 143 
Freund’s Adjuvant (CFA) from AMSbio (Abingdon, UK), Ovalbumin and Evans blue from 144 
Sigma-Aldrich (Poole, UK). The following primary antibodies were used for 145 
immunofluorescence labelling for confocal imaging: rat anti–mouse LYVE-1 mAb (clone 146 
ALY7; Thermofisher, Hatfield, UK); rabbit anti-human LYVE-1 Ab (polyclonal PA1-16635, 147 
Thermofisher), non-blocking rat anti–mouse CD31 mAb (clone C390, Thermofisher); rat anti-148 
mouse/human HEV mAb (clone MECA79, Thermofisher), rat anti-mouse GR1 mAb (clone 149 
RB6-8C5, Thermofisher), rat anti-mouse CD144 mAb (VE-Cadherin, clone BV14, 150 
Thermofisher), rat anti–mouse MRP14 mAb (clone 2B10; a gift from N. Hogg, Cancer 151 
Research UK, London, UK), rat anti-mouse F4/80 mAb (clone BM8, Biolegend, London, UK), 152 
rat anti-mouse CD115 mAb (clone AFS98, Biolegend), mouse anti-heparan sulfate (HS) mAb 153 
(10E4 epitope, clone F58-10E4, AMSbio), rabbit anti-hyaluronic acid Ab (polyclonal ab53842, 154 
Abcam, Cambridge, UK) and rabbit anti-mouse/human heparanase I Ab (polyclonal ab85543, 155 
Abcam). Isolectin-B4 (IB4), Maackia amurensis Lectin-1 (MAL-1), Sambucus nigra 156 
Agglutinin (SNA) and succinylated wheat germ agglutinin (sWGA) and their respective 157 
inhibitor carbohydrates (Galactose, lactose, N-acetylglucosamine) were purchased from Vector 158 
Labs (Peterborough, UK). All antibodies and lectins were fluorescently labelled using Alexa-159 
fluor protein labelling kits as per manufacturer’s recommendations (ThermoFisher Scientific, 160 
Paisley, UK). The non-anticoagulant heparanase inhibitor N-desulfated/re-N-acetylated 161 
heparin (NAH) was sourced from Iduron (Alderley Edge, UK).  162 
Animals, treatment and induction of tissue inflammation 163 
All experiments were approved by the local biological service unit Ethical Committee at Queen 164 
Mary University of London and carried out under the Home Office Project Licenses (70/7884 165 
& P873F4263) according to the guidelines of the United Kingdom Animals Scientific 166 
Procedures Act (1986). Wild-type C57BL/6 male mice (8-12 weeks, Charles Rivers Margate, 167 
UK) were anaesthetised with isofluorane and the cremaster muscles were stimulated for up to 168 
16hrs via intrascrotal (i.s.) injection of TNF (300ng in 300µl of PBS) or an emulsion (50:50, 169 
300µl per mouse) of CFA (200µg) with ovalbumin (200µg). Control mice were injected with 170 
300μl of PBS. To induce ear inflammation, anaesthetised animals received a subcutaneous 171 
(s.c.) injection of 300ng/30µL of TNF (or PBS as control) in the dorsal ear skin for 16hrs. To 172 
inhibit heparanase activity, the non-anticoagulant heparanase inhibitor N-desulfated/re-N-173 
acetylated heparin (NAH) was injected locally (30ug/mouse, i.s.) 3hrs after the injection of 174 
TNF.  For neutrophil depletion experiments, mice were injected intraperitoneally (i.p.) with 175 
25µg/mouse/day of anti-GR1 antibody for 3 days preceding the induction of the inflammatory 176 
response. This technique, developed in our lab (Voisin et al., 2009) leads to a specific depletion 177 
of neutrophils (>99%) but not inflammatory monocytes from the blood circulation 178 
(Supplementary Figure 3). At the end of all in vivo experiments, animals were humanely killed 179 
by cervical dislocation in accordance with UK Home Office regulations and the tissues were 180 
removed for subsequent analysis. 181 
Fluorescent staining of whole-mount murine tissues  182 
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Cremaster tissues: The labelling of blood and lymphatic vessels of the cremaster muscles in 183 
vivo was achieved as previously described (Arokiasamy et al., 2017). Briefly, the animals 184 
received an i.s. injection of the non-blocking dose of a fluorescently-labelled anti-LYVE-1 185 
mAb (2 μg/mouse, Alexa555 conjugated) and/or a fluorescently-labelled non-blocking anti-186 
CD31 mAb (2 μg/mouse, Alexa488, Alexa555 or Alexa647 conjugated depending on the 187 
antibody combination) 90 min to 2hrs before the end of the inflammatory period to label the 188 
lymphatic and blood vasculatures, respectively. To label the glycocalyx sugar residues and HS, 189 
the animals also received an i.s. injection of 2 μg/animal of fluorescently labelled (Alexa647) 190 
lectins, anti-HS or anti-HA mAbs (both Alexa488 conjugated) 2hrs prior to sacrificing the 191 
animals. To investigate neutrophil migration responses across post-capillary venules and 192 
migration into initial lymphatic vessels of the cremaster muscles, tissues were fixed in 4% PFA 193 
in PBS for 1 hr at 4°C, then blocked and permeabilized in PBS (containing 12.5% goat serum, 194 
12.5% fetal bovine serum [FBS] and 0.5% Triton X-100) for 4hrs at room temperature. To 195 
visualise neutrophils, macrophages or VE-Cadherin, tissues were incubated with Alexa647 196 
conjugated anti-MRP14 (0.25 μg), Alexa647 conjugated anti-F4/80 (1µg) or Alexa647 197 
conjugated anti-CD144 (1µg) mAbs, respectively, in 200 µl of PBS (with 10% FBS) per pair 198 
of cremaster tissues overnight or up to 48hrs at 4°C. To visualise Heparanase I, tissues were 199 
incubated with 2µg of anti-Heparanase I mAb in 200 µl of PBS (with 10% FBS) per pair of 200 
cremaster tissues for 48hrs at 4°C post fixation and permeabilisation. After 3 washes in PBS 201 
(30 min each), tissues were incubated with an Alexa488 conjugated goat anti-rabbit secondary 202 
mAb (Thermofisher) for 4hrs. For all immunostaining procedures, tissues where washed in 203 
PBS thrice for a minimum of 30 min per wash prior to the visualisation of the samples by 204 
confocal microscopy. 205 
Lymph nodes: To quantify neutrophil infiltration of the cremaster draining lymph nodes, the 206 
tissues were harvested and fixed in 4% PFA in PBS for 24 hr at 4°C, then halved, blocked and 207 
permeabilized in PBS (containing 12.5% goat serum, 12.5% fetal bovine serum [FBS] and 208 
0.5% Triton X-100) for 4hrs at room temperature. Tissues were then fluorescently 209 
immunostained for neutrophils (0.25 μg/100 μl anti-MRP14 mAb, Alexa647 conjugated)), high 210 
endothelial venules (HEV, 0.25 μg/100 μl of anti-HEV mAb, Alexa488 conjugated) and 211 
capsula/trabeculae (0.25 μg/100 μl of anti-LYVE-1 mAb, Alexa555 conjugated), in PBS (with 212 
10% FBS) overnight at 4°C prior to the visualisation of the tissues by confocal microscopy. 213 
Ear skin: Ears were harvested and fixed in 4% PFA for 1 hr at 4°C. The two ear flaps were 214 
then separated and the skin was blocked and permeabilized in PBS (containing 12.5% goat 215 
serum, 12.5% fetal bovine serum and 0.5% Triton X-100) for 4hrs at room temperature. Tissues 216 
were then fluorescently incubated with 0.25 μg of Alexa488 conjugated anti-MRP14 mAb, 1μg 217 
of Alexa647 conjugated lectin (IB4, MAL-1 or sWGA) and 1μg of Alexa555 conjugated anti-218 
LYVE-1 mAb in 200µL per ear in PBS (with 10% FBS) overnight at 4°C prior to the 219 
visualisation of the tissue by confocal microscopy.  220 
Fluorescent staining of human skin sections 221 
Paraffin sections of 4 human breast skin samples from breast carcinoma patients (6µm thick 222 
sections) were obtained from the Breast Cancer Now Tissue Bank at the Barts Cancer Institute, 223 
QMUL, with ethical permission. The samples were from distal from breast carcinomas. 224 
Hematoxylin and eosin pre-staining from an independent pathologist confirmed the absence of 225 
tumour cells in our samples with low to moderate levels of perivascular lymphocytic 226 
infiltration. Sections were dewaxed in 2× xylene and 2× 100% ethanol baths for 5 minutes 227 
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each, and antigen retrieval was performed at pH 9 in a citrate buffer (Vectorlabs) for 30 minutes 228 
at 95˚C following the antibody supplier’s guidelines. The sections were then blocked at room 229 
temperature with 10% FBS in PBS for 30 min followed by a 48hrs incubation at 4˚C with the 230 
rabbit anti-LYVE-1 antibody (1/200), anti-HS antibody (1/200) or one of our lectins (IB4, 231 
MAL-1 or sWGA) in PBS with 0.5% FBS. Samples were washed thrice with PBS for 15 232 
minutes prior to visualisation by confocal microscopy. 233 
Confocal microscopy and image analysis 234 
All samples were imaged with either a Leica SP5 or Leica SP8 confocal microscope (Leica 235 
microsystem, Milton Keynes, UK) with the use of a 20× water-dipping objective (NA:1.0). 236 
Three-dimensional confocal images from mouse and human samples were analysed using 237 
IMARIS software (Bitplane, Zurich, Switzerland) or FIJI/Image J (NIH, Bethesda, USA). 238 
Mouse cremaster muscles and ear skin : Images of lymphatic initial capillary vessels (LVs) 239 
and blood post-capillary venules (BVs) (~ 5 vessels per tissue) were acquired using sequential 240 
scanning of different channels at every 0.52µm of tissue depth at a resolution of 1024×470 and 241 
1024×800 pixels in the x×y plane, respectively. This resolution of pixels correspond to a voxel 242 
size of 0.45×0.45×0.52µm in x×y×z. BV and LV were imaged at a zoom factor of ×1.9 and 243 
×1.2, respectively. On average, a serial stack of ~60 and ~150 optical sections were acquired 244 
for BV and LV images, respectively. To assess the expression (i.e. mean fluorescence intensity 245 
measurements) of glycocalyx components, image settings (laser power, detector gain and 246 
offset) were first defined (and kept constant for each specific molecules and treatment groups) 247 
using samples stained with a control isotype-matched antibody (e.g. HS) or a lectin of interest 248 
pre-incubated with an inhibitory carbohydrate. To inhibit IB4, MAL-1 or sWGA binding 249 
activity, the lectins were pre-incubated with 50mM of galactose, lactose or N-250 
Acetylglucosamine, respectively, for 1hr prior to their use in murine tissues (Supplementary 251 
Figure 1). Quantification of neutrophil extravasation and migration into tissue-associated LVs 252 
were analysed with IMARIS software as previously described (Arokiasamy et al., 2017). 253 
Specifically, extravasated neutrophils were defined as the number of neutrophils present in the 254 
interstitium across a 300µm blood vessel segment and within 50μm from each side of the 255 
venule of interest; and data are expressed as the number of neutrophils per volume of tissue. 256 
The neutrophil intravasation response was defined as the number of neutrophils present inside 257 
the lymphatic vessels as visualised in 3D and quantified by IMARIS Software and data were 258 
expressed as cell number per given volume of LV. LV volume were quantified by the IMARIS 259 
software following the creation of  a 3D-isosurface on the LYVE-1 channel (thus excluding 260 
MRP14+ and CD31high regions) and mean fluorescent intensity measurements of the glycocalyx 261 
components associated exclusively with LV where quantified within this isosurface. A similar 262 
strategy was done for the blood vessels (i.e. isosurface only on CD31high regions). 263 
Lymph nodes: Images (12 images per pair of LNs per mouse) were obtained with the use of 264 
sequential scanning of different channels at every 0.7 μm of tissue depth at a resolution of 265 
1024 × 1024 pixels in the x × y plane and with a zoom factor of 0.75, corresponding to a voxel 266 
size of 0.91 × 0.91 × 0.7 μm in x × y × z. On average, a serial stack of ~30 optical sections were 267 
acquired. Quantification of neutrophil recruitment into the dLNs were analysed with the 3D-268 
reconstructing image processing software IMARIS. Recruited neutrophils were defined as the 269 
number of neutrophils per volume of tissue, excluding the blood circulating neutrophils present 270 
in HEVs. 271 
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Human skin sections: Images of lymphatic vessels (LVs) were acquired using sequential 272 
scanning of different channels at every 0.52µm of tissue depth at a resolution of 1024×300 273 
pixels in the x×y plane with a zoom factor of 1, respectively with a resolution of 0.45×0.45 µm 274 
in x × y plans. On average, a serial stack of ~30 optical sections were acquired, overlapping 275 
the 6 µm thick tissue section. Lymphatic vessels were confirmed by the presence of LYVE-1+ 276 
vessels, morphology and the absence of erythrocytes in the lumen. The expression of lectin-277 
binding moiety and HS on LVs was analysed by FIJI/Image J by delimitating a surface area 278 
around LYVE-1+ regions of LVs. 279 
Lymphatic drainage analysis 280 
To visualise the drainage capability of lymphatic vessels of the mouse cremaster muscle in 281 
vivo, animals received an i.s. injection of Evans Blue in PBS (1%, 300µL) 20 minutes prior to 282 
the end of the inflammatory period. The cremaster muscles, draining (inguinal) and non-283 
draining (brachial) LNs were then harvested, snap frozen in liquid nitrogen and the blood of 284 
the animal was recovered by cardiac puncture. The blood was then centrifuged and plasma 285 
collected. For the cremaster muscles and LNs, tissues were incubated in 100% formamide at 286 
56˚C overnight prior to spectrophotometry analysis. The quantity of Evans Blue in plasma and 287 
tissues samples was quantified with a spectrophotometer at an absorbance wavelength of 288 
620nm.  289 
Blood vascular leakage analysis 290 
Blood vascular leakage (and lymphatic drainage) was assessed using the Mile’s Assay 291 
(Finsterbusch et al., 2014). Briefly, two hours before the end of the TNF stimulation (i.e. 292 
16hrs), Evans blue dye (0.5% in PBS, 5 µl/g) was injected i.v. At the end of the experiment, 293 
animals were sacrificed, and the cremaster muscles were harvested and incubated in 100% 294 
formamide (Sigma-Aldrich) at 56°C for 24 h. The amount of accumulated Evans blue in the 295 
tissue supernatant was then quantified by spectroscopy at 620 nm. 296 
Statistical analysis 297 
Data are presented as mean±S.E.M per mouse. Significant differences between multiple groups 298 
were identified by one-way or two-way analysis of variance (ANOVA), followed by Newman-299 
Keuls/Sidak’s Multiple Comparison Test. Whenever two groups were compared, Student’s t 300 
test was used. P-values < 0.05 were considered significant.  301 
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RESULTS 302 
Characterization of the glycocalyx of initial lymphatic capillaries in vivo 303 
To compensate for the lack of knowledge regarding the composition and role of initial 304 
lymphatic vessel (LV) glycocalyx, in this study we first aimed to investigate the expression 305 
profile of carbohydrate moieties present on initial LV of mouse cremaster tissues. This thin and 306 
transparent muscle contains an extensive lymphatic vasculature amenable for whole-mount 307 
fluorescent staining and 3-dimensional visualisation of cellular and molecular structures in vivo 308 
by confocal microscopy (Figure 1A)(Arokiasamy et al., 2017). Interestingly, cremaster LVs 309 
are composed mainly of lymphatic endothelial cells (LECs) with discontinuous junctions 310 
organised in flaps and VE-Cadherin-enriched buttons (Figure 1A) (Baluk et al., 2007).  To 311 
visualise the glycocalyx of those initial lymphatic vessels we used several fluorescently-312 
labelled lectins, namely Isolectin-B4 (IB4), Maackia Amurensis Lectin-1 (MAL-1), Sambucus 313 
Nigra Agglutinin (SNA) and succinylated Wheat Germ Agglutinin (sWGA). These lectins 314 
specifically recognise -D-galactosyl moieties (IB4), sialic acid α2,3-linked (MAL-1) or -315 
2,6-linked (SNA) galactose/N-acetylgalactosamine residues and N-acetylglucosamine chains 316 
(sWGA). Additionally, an anti-heparan sulfate (HS) or anti-hyaluronic acid (HA) monoclonal 317 
antibody was employed to visualise heparan sulfate chains and hyaluronan, respectively. 318 
Lectins and anti-HS/anti-HA antibodies were injected i.s. in conjunction with non-blocking 319 
and fluorescently-labelled anti-LYVE-1 and anti-CD31 mAbs to differentiate the lymphatic 320 
and blood vasculatures, respectively, as described previously (Arokiasamy et al., 2017). 321 
Animals were sacrificed ~2hrs later, and the cremaster muscles were removed and fixed prior 322 
to visualisation and image acquisition (whole mount) by confocal microscopy. Image series 323 
were then analysed in 3-dimensions using IMARIS software to quantify the fluorescence 324 
intensity for each specific marker binding the glycocalyx moieties associated exclusively with 325 
LVs (i.e. LYVE-1+ vessels). The specificity of lectin/antibody binding to their respective 326 
glycocalyx moieties in whole-mount tissues was confirmed using competitive sugar binding 327 
assays (with the use of specific inhibitory sugars for each lectins) or with isotype-matched 328 
control antibodies, respectively (Supplementary Figure 1). Our data show that in vivo the 329 
glycocalyx of initial lymphatic capillaries from cremaster tissues contains HS, -D-galactosyl 330 
moieties, α-2,3-linked sialic acid residues and N-acetylglucosamine chains on as exemplified 331 
by the capacity of anti-HS mAb, IB4, MAL-1 and sWGA to bind the glycocalyx of these 332 
vessels whilst α-2,6-linked sialic acid residues (SNA ligand) could not be detected (Figures 333 
1B & 1C). Interestingly, hyaluronan was minimally associated with lymphatic glycocalyx of 334 
naïve LVs (Figure 1B & 1C) but strongly expressed by interstitial cells morphologically 335 
resembling to macrophages or dendritic cells (Supplementary Figure 2). Of note, the 336 
deposition of those glycocalyx moieties was neither associated specific morphological 337 
structures of initial lymphatic ECs nor with the low expression regions of basement membrane 338 
of LVs (Pflicke and Sixt, 2009). Further analysis of our images, however, demonstrated that 339 
the intensity of fluorescence of anti-HS Ab, IB4 and sWGA (but not MAL-1) was inversely 340 
proportional to the vessel size (Figure 1D); suggesting that HS, α-D-galactosyl and N-341 
acetylglucosamine moieties were more abundant on small initial capillaries than in larger 342 
vessels, whilst sialic acid levels were constant. Interestingly, similar pattern of expression of 343 
HS, -D-galactosyl moieties, α-2,3-linked sialic acid residues and N-acetylglucosamine 344 
chains, were observed on the LVs of the mouse ear skin (Figure 2A-C) but also on the LVs in 345 
human breast skin tissue sections (Figure 2D-E). When comparing the intensity of 346 
fluorescence of the lectins binding to initial lymphatics and blood vessels (post-capillary 347 
venules) of the mouse cremaster muscles, we observed that both vasculatures were 348 
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characterised by the presence of -D-galactosyl moieties, α2,3-linked (but not α2,6-linked) 349 
sialic acids and N-acetylglucosamine chains. Of note, we noticed that IB4 had a greater affinity 350 
for the glycocalyx of blood post-capillary venules whilst MAL-1 showed a trend towards a 351 
higher binding to LVs (Figures 3A & 3B).  352 
Collectively, our data demonstrate that in vivo the glycocalyx of initial lymphatic capillaries 353 
includes HS, α-D-galactosyl moieties, sialic acid α-2,3 -linked glycans and, to a lesser extent 354 
N-acetylglucosamine residues in both mouse and human tissues. 355 
 356 
The glycocalyx of initial lymphatic vessels is remodelled during inflammation 357 
Having observed the binding of the anti-HS mAb, IB4, and MAL-1, but not SNA to the 358 
lymphatic capillaries in vivo, we next investigated the potential regulation of LV glycocalyx 359 
during acute inflammation. For this purpose, the cremaster muscles of mice were first subjected 360 
to acute TNF-induced inflammation, a cytokine we have previously shown to induce the rapid 361 
migration of neutrophils into the tissue-associated lymphatic vessels (Arokiasamy et al., 2017). 362 
For this purpose, the cytokine was injected i.s. for 16hrs prior to fluorescent staining of tissues 363 
with anti-HS Ab, anti-LYVE-1 and anti-MRP-14 mAb to visualise HS, lymphatic vasculature 364 
and neutrophils, respectively. Our data showed that TNF-stimulation induces the rapid 365 
migration of neutrophils into the tissue and the lymphatic vasculature (Figures 4A-D). Of note, 366 
we did not observed preferred entry sites for neutrophils migration within LVs and with regards 367 
to glycocalyx components. However, we detected a significant decrease (~64%) in HS 368 
expression on LVs of TNF-stimulated tissues as observed by a reduced binding of the anti-HS 369 
mAb (Figures 4A & 4E). Similarly, we observed a reduction in staining for IB4 but not MAL-370 
1, suggesting a decrease in galactosyl residues (~3 fold decrease as compared to unstimulated 371 
lymphatic glycocalyx) but not sialic acid α-2,3-linked glycans following TNF-stimulation 372 
(Figures 5A & 5B). Similar results were obtained in another inflammatory model as induced 373 
by antigen sensitisation (i.e. injection of an emulsion of ovalbumin in Complete Freund’s 374 
Adjuvant, CFA+Ag) (Figures 5A & 5B). This remodelling of LV glycocalyx was associated 375 
with the recruitment of neutrophils into the interstitium and the tissue-associated lymphatic 376 
vessels in both inflammatory models (Figures 5C & 5D).  Finally, to confirm that the LV 377 
glycocalyx remodelling was not restricted to inflamed cremaster muscles, similar analyses 378 
were performed in the mouse ear dorsal skin (Figure 5E-H). Our data clearly demonstrate that 379 
ear skin LVs also exhibit a cleavage of α-D-galactosyl moieties but not sialic acids following 380 
TNF-stimulation; a response associated with neutrophil infiltration into the tissue and 381 
migration into LVs (Figure 5E-H). 382 
Collectively, these results provide evidence for moiety-specific remodelling of the LV 383 
glycocalyx in two distinct vascular beds, a response that is associated with neutrophil 384 
trafficking into inflamed tissues and LVs.  385 
 386 
Neutrophils do not contribute to the remodelling of the LEC glycocalyx of initial lymphatic 387 
vessels 388 
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Having associated the remodelling of the glycocalyx of tissue-associated initial lymphatic 389 
capillaries with extensive neutrophil recruitment during acute inflammation, we then 390 
investigated the contribution of these leukocytes to this remodelling. Neutrophils from the 391 
blood circulation are known to secrete proteases (e.g. elastase) (Champagne et al., 1998) and 392 
release reactive oxygen species (ROS) (van Golen et al., 2012), that can cleave or modify 393 
glycoproteins at the surface of BECs during their recruitment (i.e. ICAM-1), thus contributing 394 
to the modification of the composition of the blood vascular glycocalyx. To directly assess a 395 
similar role of neutrophils during their entry into LVs, we performed antibody-based depletion 396 
of neutrophils prior to the induction of TNF-induced inflammation of the mouse cremaster 397 
muscles and analysis of the response (i.e. HS and IB4 expression profile, and neutrophil 398 
migration) by confocal microscopy. Antibody-based depletion efficiency was first confirmed 399 
by the absence of detection of neutrophils in the blood circulation (Supplementary Figure 3) 400 
and in the inflamed tissues and their associated LVs as compared to animals treated with an 401 
isotype-matched control Ab (Figures 6A & 6B).  Interestingly, however, neutrophil-depleted 402 
animals showed a similar level of LV glycocalyx remodelling (reduced detection of both for 403 
α-D-galactosyl residues and HS) following TNF-stimulation that of non-depleted animals 404 
(Figures 6C & 6D). These observations suggest that neutrophils are not responsible for the 405 
shedding of HS & Galactosyl moieties present lymphatic glycocalyx during TNF-induced 406 
inflammation in vivo. 407 
 408 
Endogenous Heparanase contributes to the remodelling of initial lymphatic glycocalyx  409 
Since tissue-infiltrated neutrophils did not contribute to the remodelling of lymphatic 410 
glycocalyx in vivo, we next sought to investigate the role of endogenous glycosidases in 411 
glycocalyx degradation. Interestingly, a study by Schmidt et al. has demonstrated that the HS-412 
specific endoglycosidase, Heparanase, is responsible for the cleavage of the glycan layer on 413 
the luminal side of blood capillaries in the lung during sepsis (Schmidt et al., 2012). To address 414 
the hypothesis that this enzyme may also be involved in the remodelling of the initial lymphatic 415 
glycocalyx during an acute inflammatory response, we first investigated its cellular source. For 416 
this purpose, TNF-stimulated cremaster muscles were immunostained with antibodies against 417 
Heparanase I (or with an isotype control antibody, Supplementary Figure 4), lymphatic 418 
(LYVE-1) and blood (CD31high) vasculatures and neutrophils (MRP14) or macrophages 419 
(F4/80) prior to analysis by confocal microscopy. Heparanase I is an endo-β-glucuronidase 420 
implicated in the degradation of HS chains and known to be expressed by leukocytes, platelets 421 
and blood endothelial cells (Miao et al., 2002;Vlodavsky et al., 2013;Mayfosh et al., 2019). In 422 
our in vivo inflammatory model, confocal image analyses showed that this enzyme was not 423 
associated with LVs post TNF-stimulation but with interstitial cells (Figure 7A). In fact, 424 
Heparanase I was strongly detected in macrophages whilst the tissue-infiltrated neutrophils did 425 
not exhibit a positive immunostaining for this enzyme (Figures 7B & 7C). Similar pattern of 426 
Heparanase I expression was observed at an early (8hrs) time-point of the inflammatory 427 
reaction (Data not shown). 428 
To get further mechanistic insights into the role of Heparanase into the remodelling LV HS 429 
during inflammation, we tested the effect of local injection of a non-anticoagulant heparanase 430 
inhibitor N-desulfated/re-N-acetylated heparin (NAH). Briefly, TNF-stimulated cremaster 431 
muscles were treated locally (i.s. injection) with NAH, or its vehicle, 3hrs post administration 432 
of TNF. Two hours before the end of the inflammatory period (i.e. 16hrs), the tissues were 433 
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fluorescently immunostained with anti-LYVE-1 and anti-HS Abs to visualise the lymphatic 434 
vasculature and HS respectively. In addition, at the end of the in vivo test period, tissues were 435 
harvested, fixed and immunostained with an anti-MRP14 Ab to enable quantification of 436 
neutrophil migration responses. In line with our previous results (Figure 4), vehicle-treated 437 
tissues exhibited a decrease in anti-HS Ab immunostaining on initial LVs upon TNF-438 
stimulation (Figures 8A & 8B). Interestingly, inflamed tissues treated with NAH showed a 439 
similar deposition of HS as found in un-stimulated cremaster muscles (Figures 8A & 8B), 440 
confirming the role of endogenous heparanase for the remodelling of LEC glycocalyx during 441 
TNF-induced inflammation in vivo. In contrast, however, local administration of NAH had no 442 
significant impact on neutrophil migration into tissues and tissue-associated LVs as compared 443 
to vehicle-treated animals (Figures 8C & 8D). Furthermore, NAH-treatment did not inhibit 444 
neutrophil trafficking to the cremaster draining lymph nodes (Figures 8E). Collectively, these 445 
results suggest that local inhibition of heparanase-dependent shedding of HS on initial LVs 446 
does not affect the capacity of neutrophils to infiltrate the tissue-associated lymphatic 447 
vasculature.  448 
 449 
Blockade of initial LV glycocalyx shedding prevents local fluid drainage of TNF-stimulated 450 
cremaster muscles   451 
Whilst innate immune cell trafficking is an important aspect of lymphatic biology, a key 452 
function of tissue-associated initial lymphatic capillaries is to transport fluids and 453 
macromolecules (including antigens) out of the interstitium into dLNs (for immune 454 
surveillance) and back into the blood circulation. Tissue drainage by LVs naturally occurs at 455 
steady state but also during inflammatory responses; but can be impaired during pathological 456 
conditions such as ageing (Zolla et al., 2015). Nevertheless, the current literature lacks 457 
convincing in vivo evidence for a role of lymphatic glycocalyx in this phenomenon in the 458 
context of acute inflammation. The aim of this last set of experiments was thus to determine 459 
how the remodelling of the lymphatic glycocalyx influences the draining capabilities of these 460 
vessels. For this purpose, we investigated the draining function of initial lymphatic capillaries 461 
of mouse cremaster muscles by injecting locally (i.s.) an isotonic solution of Evans Blue (EB) 462 
before measuring the quantity of the dye in cremaster muscles, draining and non-draining LNs 463 
as well as in the plasma of animals treated locally with the heparanase inhibitor NAH. 464 
Lymphatic drainage of EB was first confirmed by direct visualization of the dye in the lymph 465 
nodes and lymphatic venules (i.e. inguinal) draining the cremaster muscles (Supplementary 466 
Figure 5A). These observations were supported by the significant reduction of EB levels 467 
(~30%) in TNF-stimulated cremaster muscles as compared to non-inflamed tissues (Figure 468 
9A). Interestingly, whilst in non-inflamed conditions NAH did not modify EB drainage 469 
(Supplementary Figure 5B), treatment of TNF-stimulated tissues with this inhibitor restored 470 
EB levels to that seen in non-inflamed control tissues (Figure 9A). Furthermore, whilst TNF 471 
stimulation led to an increase in EB detection in dLNs (~180% increase) and plasma (~100% 472 
increase), as compared to unstimulated tissues, these responses were significantly suppressed 473 
in NAH-treated mice (Figures 9B & 9C). Of note, no EB could be detected in non-draining 474 
(i.e. brachial) LNs (Figure 9D), suggesting that our responses is mainly due to lymphatic 475 
drainage rather than potential diffusion of the locally-injected dye into blood capillaries. 476 
Furthermore, to exclude the possibility that blood vascular hyper-permeability may increase 477 
interstitial pressure (and thus, lymphatic drainage) within the tissues during inflammation, we 478 
sought to investigate the extent of blood vascular leakage at time of glycocalyx remodelling 479 
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and lymphatic drainage using the Miles assay. Briefly, mice were injected with TNF (or PBS 480 
as control) prior to be treated locally with the heparanase inhibitor NAH (or vehicle control) 481 
3hrs later. Two hours before the end of the inflammatory period (i.e. 16hrs), animals received 482 
an intravenous injection of 0.5% of Evans blue. The quantity of dye present in the cremaster 483 
muscles was then assessed by spectrophotometry. Our data show that of the accumulation of 484 
Evans blue in tissues was similar between unstimulated and TNF-stimulated groups 485 
(Supplementary Figure 6). Furthermore, NAH treatment did not affect vascular permeability 486 
response at this time point. These observations are supported by a previous study from our 487 
group demonstrating that in vivo, TNF promote a rapid but transient blood vascular leakage 488 
during the first 30 min post stimulation (Finsterbusch et al., 2014). Together, these results 489 
suggest that the enhanced lymphatic drainage response that we observed during glycocalyx 490 
remodelling upon TNF-inflammation occurred independently of blood vascular leakage at the 491 
time-point analysed.   492 
Collectively, these results suggest that protecting the lymphatic glycocalyx HS from 493 
heparanase-induced shedding during TNF-induced inflammation reduces the capacity of initial 494 
lymphatic vessels to drain interstitial fluids towards draining lymph nodes and back into the 495 
blood circulation.    496 
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DISCUSSION 497 
The lymphatic vasculature is the second circulatory system of high vertebrates and is formed 498 
by a unidirectional network of vessels and dLNs that starts in tissues with blunt-ended initial 499 
lymphatic capillaries. The main function of these specialised vessels is to remove interstitial 500 
fluids and macromolecules to counteract tissue oedema and as such are essential for tissue 501 
homeostasis (Baluk et al., 2007). Initial lymphatic capillaries also play a key role in immune 502 
surveillance by allowing not only the rapid drainage of antigens and migration of professional 503 
antigen-presenting cells such as DCs and macrophages but also neutrophils towards the dLNs 504 
in order to initiate adaptive immune responses (Teijeira et al., 2013;Arokiasamy et al., 2017). 505 
Initial lymphatic capillaries are composed of a monolayer of endothelial cells (LECs) that share 506 
some molecular similarities with blood endothelial cells (BECs) but also a few architectural 507 
and phenotypic differences (Baluk et al., 2007). Furthermore, whilst both BECs and LECs 508 
contain a carbohydrate-rich glycocalyx layer on their cell surface, the characteristics of the 509 
glycocalyx of initial lymphatic vessels in vivo and its role in acute inflammation is unknown. 510 
In an effort to gain insight into the characteristics of the composition of glycan residues forming 511 
the glycocalyx of initial lymphatic vessels, an antibody targeting the most abundant glycan 512 
moiety of endothelial glycocalyx, HS, alongside a panel of 4 lectins (IB4, MAL-1, SNA and 513 
sWGA) were used in vivo in the mouse cremaster muscle. Lectins are the most commonly 514 
employed glycan-binding glycoproteins used to label the blood vascular glycocalyx, especially 515 
IB4 that binds α-D-galactosyl moieties present at the luminal surface of microvascular 516 
endothelial cells (Scruggs et al., 2015). In contrast, lectins have not been systematically used 517 
to investigate the LEC glycocalyx in vivo. In our study, we demonstrate that IB4, MAL-1 and 518 
to a lesser extent sWGA, can successfully bind lymphatic vessels. Similar pattern of expression 519 
of those glycocalyx moieties was observed to be also present in lymphatic vessels from the 520 
mouse murine ear skin and in human breast skin samples. Interestingly, we noted a higher 521 
staining for IB4 on blood vessels than on initial lymphatic capillaries of mouse cremaster 522 
muscles. This difference in the binding level of IB4 on these two distinct vasculatures could be 523 
attributed to the fact that blood vessel walls are surrounded by smooth muscle cells and 524 
pericytes known to exhibit IB4-binding carbohydrate residues in their own glycocalyx (Scruggs 525 
et al., 2015) that would be also revealed by the local delivery of the lectin employed in our 526 
study. In contrast, initial lymphatic vessels are usually devoid of perivascular cells and are only 527 
composed of a monolayer of LECs surrounded by a thin and perforated basement membrane 528 
(Pflicke and Sixt, 2009), hence the overall lower detection of α-D-galactosyl moieties on initial 529 
lymphatics as compared to blood vessels. In contrast, MAL-1 but not SNA, both of which have 530 
been used in a plethora of studies to detect different sialic acid-linked glycans (Wang and 531 
Cummings, 1988;Knibbs et al., 1991;Nicholls et al., 2007;Khatua et al., 2013) was found to 532 
bind the LEC glycocalyx to the same extent as BEC glycocalyx. MAL-1 expression on 533 
lymphatic glycocalyx could be related to the expression of lymphatic glycoproteins such as of 534 
LYVE-1 and podoplanin by LECs, molecules exhibiting high levels of α2,3-linked sialic acid 535 
moieties (Nightingale et al., 2009;Ochoa-Alvarez et al., 2012). In support of our findings, a 536 
study by Nightingale et al. showed that the level of MAL-1 binding to the surface of human 537 
dermal LECs in vitro was higher than of SNA (Nightingale et al., 2009), whilst being similar 538 
for other cell types (Natunen et al., 2013). Altogether, these results suggest that the glycocalyx 539 
of LECs exhibit more α2,3-sialic acid linked moieties (i.e. MAL-1 ligands) than α2,6-sialic 540 
acid linked glycans (i.e. SNA ligand).  541 
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We further characterised the glycocalyx of tissue lymphatic capillaries by revealing the 542 
presence of HS on those vessels. HS proteoglycans represent the majority of all proteoglycans 543 
expressed by BECs, and as such HS is the major constituent of the blood vascular glycocalyx, 544 
representing more than 50% of the vascular GAGs present on those vessels (Kolarova et al., 545 
2014). GAGs have the capacity to bind and immobilise chemokines for leukocyte recruitment 546 
to blood vessels. This is particularly the case for CXCL1 and CXCL2, two potent neutrophil 547 
chemoattractants (Wang et al., 2005;Proudfoot et al., 2017). HS was also shown to protect 548 
endothelial cells from oxidative stress damage by quenching reactive oxygen species (ROS) 549 
through the binding of superoxide dismutase enzyme to GAG HS and to maintain nitric oxide 550 
bioactivity (Gouverneur et al., 2006). In the lymphatic system, HS has been implicated in the 551 
formation of a CCL21 gradient within the interstitium in the vicinity of the LVs in order to 552 
direct dermal DCs towards LVs, as indirectly demonstrated by the inhibitory effect of a 553 
bacterial heparinase on CCL21 gradient formation and DC recruitment to LVs (Weber et al., 554 
2013). Similarly, transgenic mice exhibiting impairment in HS synthesis showed a defect in 555 
DC and naïve T-cell trafficking into the lymph nodes via high endothelial venules (Bao et al., 556 
2010). In this context, we have recently demonstrated that during TNF-induced inflammation 557 
and antigen challenge, tissue-infiltrated neutrophils rapidly migrate into the lymphatic system 558 
through initial lymphatic capillaries (Arokiasamy et al., 2017), a process occurring in a strictly 559 
CCL21/CCR7 dependent manner. However, at present little is known about the regulation and 560 
role of tissue-associated lymphatic glycocalyx and HS during inflammation, and it is still 561 
unclear whether the LEC glycocalyx can regulate the migratory response of these leukocytes, 562 
a topic that needs further explorations.  563 
Another important GAG associated with lymphatic vessels is Hyaluronan (HA). In fact, LECs 564 
from initial lymphatics are characterised by the expression of the specific marker LYVE-1, a 565 
transmembrane molecule that is known to be the lymphatic receptor for HA (Jackson, 2018). 566 
Recently, an elegant study by Johnson et al. showed that LYVE-1 serves as a docking structure 567 
for migrating DCs. Specifically, the authors propose that HA, secreted by DCs, create a bridge 568 
between the receptor LYVE-1 and CD44 on LECs and the leukocytes, respectively (Johnson 569 
et al., 2017). Whilst HA and CD44 are important for neutrophil adhesion to blood vessels 570 
(Khan et al., 2004;McDonald and Kubes, 2015), to date, there is no evidence of a similar 571 
mechanism for neutrophil interaction with LECs. In fact, most studies have demonstrated that 572 
neutrophils preferentially use β2-integrins (binding to ICAM-1 on LECs) during their 573 
migration into lymphatic vessels (Gorlino et al., 2014;Hampton et al., 2015;Arokiasamy et al., 574 
2017). 575 
There is an abundance of literature reporting the remodelling of the blood vascular glycocalyx 576 
during inflammation. Specifically, the BEC glycocalyx and in particular HS proteoglycans are 577 
rapidly shed in response to inflammation as induced by cytokines such as TNF, but also in 578 
various experimental and pathological inflammatory conditions such as ischemia reperfusion 579 
injury or sepsis (Chappell et al., 2009;Becker et al., 2010;Kolarova et al., 2014). HS 580 
degradation during inflammation appears to allow the exposure of underlying adhesion 581 
molecules (e.g. ICAM-1, VCAM-1) and the release of pro-inflammatory chemokines, thus 582 
facilitating neutrophil adhesion and extravasation through the blood vessel wall (Reitsma et al., 583 
2007;Schmidt et al., 2012). Conversely, an intact layer of HS proteoglycans in physiological 584 
and homeostatic conditions has been associated with inhibition of neutrophil adhesion to BECs 585 
(Schmidt et al., 2012). Mechanistically, cleavage of BEC glycocalyx has been suggested to be 586 
partially as a consequence of the activation of leukocytes such as neutrophils through their 587 
release of enzymes and ROS (Henry and Duling, 2000;VanTeeffelen et al., 2007;van Golen et 588 
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al., 2012). However, there is no evidence to date of a similar phenomenon during acute 589 
inflammation at the level of tissue-associated lymphatic capillaries. Of relevance however, 590 
Zolla et al. have recently described the thinning of the glycocalyx of mesenteric afferent 591 
lymphatic collecting venules in aged rats (Zolla et al., 2015). Here, we provide the first 592 
conclusive evidence for reduced HS and α-D-galacosyl moieties on initial lymphatic 593 
glycocalyx during acute inflammatory responses elicited in the mouse cremaster muscle. 594 
Furthermore, this response, elicited by TNF or antigen sensitisation, was associated with the 595 
migration of neutrophils into the lymphatic vasculature. Interestingly, in neutrophil-depleted 596 
animals, the degradation of the lymphatic glycan layer still occurred, suggesting that in contrast 597 
to the cleavage of the BEC glycocalyx, this phenomenon in initial lymphatic capillaries is not 598 
mediated by neutrophils. In exploring other mechanistic pathways, we investigated the cellular 599 
source of Heparanase I, a β-D-endoglucuronidase known to be the enzyme capable to cleave 600 
HS in mammalian systems (Miao et al., 2002;Vlodavsky et al., 2013;Mayfosh et al., 2019). 601 
Heparanase expression is mainly restricted to platelets and activated leukocytes, such as T-602 
cells, macrophages, DCs and neutrophils (Mayfosh et al., 2019), but can also be upregulated in 603 
other cell types during chronic inflammatory disorders, including BECs (Chen et al., 2004). 604 
Furthermore, neutrophil Heparanase expression, has been associated with degradation of sub-605 
endothelial extracellular matrix of blood vessels (Matzner et al., 1985;Komatsu et al., 2008). 606 
However, in our acute inflammatory model, Heparanase I was neither associated with LECs 607 
nor with extravasated neutrophils but was found to be highly expressed by interstitial 608 
macrophages. Altogether, these set of data could suggest a distinct function of this enzyme 609 
during the interaction of this leukocyte with blood vessels vs. lymphatic vessels. This 610 
hypothesis is supported by our novel findings using neutrophil-depletion experiments and 611 
showing that these leukocytes are not responsible for HS remodelling of LVs during acute 612 
inflammation in vivo. In deciphering further the mechanisms of HS degradation, we 613 
demonstrated that a specific non-anticoagulant inhibitor of the endoglycosidase heparanase 614 
(NAH) blocked the shedding of HS GAGs on initial LVs. These results are supported by a 615 
study from Schmidt et al. who showed that endogenous TNF catalysed the degradation of HS 616 
constituents of the BEC glycocalyx in a heparanase-dependent manner in an experimental 617 
model of sepsis-induced acute lung injury (Schmidt et al., 2012). Similarly, Lukasz et al. 618 
demonstrated both in vitro and in vivo that angiopoietin-2 can induce the secretion of 619 
heparanase by BECs, thus contributing to the cleavage of BEC glycocalyx and resulting in an 620 
increase in blood vascular leakage and leukocyte diapedesis (Lukasz et al., 2017). In our study 621 
however, inhibition of glycocalyx cleavage did not interfere with the capacity of neutrophils to 622 
migrate into tissue-associated LVs, offering a prominent difference in the functional roles of 623 
lymphatic vs. blood vessel glycocalyx for the trafficking of these leukocytes. Since HS plays 624 
an important role in the migration of DCs (Weber et al., 2013), it is also possible that our 625 
findings suggest potential differences in the function of HS with respect to controlling the 626 
recruitment of innate immune cells to LVs as compared to neutrophils. 627 
To further understand the physiological relevance of glycocalyx shedding for lymphatic 628 
function during inflammation, we analysed the capacity of initial LVs to drain interstitial fluids 629 
and macromolecules out of inflamed tissues. Here, we showed that glycocalyx remodelling on 630 
initial lymphatic capillaries was directly associated with a rapid decrease in Evans Blue (EB) 631 
dye (locally injected to mimic tissue oedema) detection in inflamed cremaster muscles. More 632 
importantly the reduced level of EB in those tissues was inversely associated with an increase 633 
in EB detection in cremaster draining lymph nodes and within the blood circulation. Of note 634 
we did not observed differences in blood vascular permeability at this time point (i.e. 16hrs 635 
post TNF stimulation) between stimulated and unstimulated (or with NAH-treatment); 636 
suggesting that the enhanced lymphatic drainage was not the consequence of an increase in 637 
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interstitial pressure due to vascular permeability but related to glycocalyx remodelling. This 638 
results is supported by our previous publication demonstrating that TNF-induced blood 639 
vascular leakage is a rapid but transient phenomenon occurring within the first 30 mins post-640 
cytokine stimulation (Finsterbusch et al., 2014). Interestingly, however, in TNF-stimulated 641 
tissues local blockade of HS shedding with the heparanase inhibitor, NAH, led to the detection 642 
of high levels of EB in the cremaster muscles, and conversely, a lower quantity in draining 643 
lymph nodes and plasma of the treated animals. Supported by the fact that EB is highly 644 
negatively charged, these results suggest that the glycocalyx of initial lymphatic capillaries 645 
may form an electrostatic barrier to interstitial solutes and macromolecules similarly to blood 646 
vessels due to the presence of negative electric charges of GAG molecules present on LEC 647 
glycocalyx (Curry and Adamson, 2012;Kolarova et al., 2014). The degradation of the 648 
lymphatic glycocalyx could therefore contribute to the rapid drainage of excessive interstitial 649 
fluids generated by the inflammatory response, and to promote the rapid transport of antigens 650 
towards the closest draining lymph node in order to mount an adaptive immune response as 651 
required. in sharp contrast, during ageing, the thinning of the glycocalyx of large lymphatic 652 
collectors and the loss of extracellular matrix in the valve area of these vessels (Zolla et al., 653 
2015) were associated with a decrease in the capacity of lymphatic collectors to transport fluids 654 
correctly due to reduced investiture of smooth muscle cells and pericytes around the valves 655 
(Bridenbaugh et al., 2013). However, our study clearly shows that the cleavage of initial 656 
lymphatic glycocalyx is important for more efficient drainage of the tissues. Initial lymphatic 657 
capillaries are in fact structurally distinct from lymphatic collectors (Hirakawa et al., 658 
2014;Kerjaschki, 2014). Specifically, they exhibit an oak leaf-shaped monolayer of 659 
overlapping endothelial cells facilitating the rapid absorption of fluids and macromolecules as 660 
well as contributing to the migration of immune cells (Baluk et al., 2007). Initial lymphatics 661 
are also mostly devoid of perivascular cells in contrast to the large collector vessels that are 662 
covered with pericytes and smooth muscle cells. Initial lymphatics also express specific and 663 
highly glycosylated molecules such as LYVE-1 (usually absent or reduced on collecting LVs) 664 
(Banerji et al., 1999). Taken together, the unique molecular and architectural characteristics of 665 
initial lymphatics may suggest differences in the composition of the glycocalyx that may 666 
exhibit different functions as compared to the glycocalyx of large collecting venules. This is 667 
categorically supported by our findings that the cleavage of HS GAGs on initial lymphatic 668 
capillaries promotes a faster removal of interstitial fluids from inflamed tissues. 669 
 670 
In conclusion, our study has revealed the presence of α-D-Galactosyl moieties, α2,3-sialic acid-671 
linked glycans and HS as key components of the initial lymphatic capillary glycocalyx in vivo. 672 
We also demonstrate for the first time that HS and α-D-Galactosyl moieties are cleaved from 673 
the LEC glycocalyx upon inflammation, a response that appears to be mediated by endogenous 674 
heparanase activity. Interestingly, the shedding of glycocalyx components was not associated 675 
with enhanced neutrophil interaction and recruitment to lymphatic vessels, a response that is 676 
in sharp contrast with the importance of BEC glycocalyx cleavage for the migration of 677 
leukocytes through blood vessels (Reitsma et al., 2007). However, our data suggest that 678 
inflammation-induced shedding of initial lymphatic glycocalyx is important for the rapid 679 
drainage of interstitial fluids and macromolecules out of inflamed tissues into the draining 680 
lymph nodes and back into the blood circulation. This response is essential for immune 681 
surveillance and for the development of a specific adaptive immunity against foreign soluble 682 
antigens. Conversely, this phenomenon may also help with the dissemination of small 683 
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pathogens and pro-inflammatory mediators into the body, thus potentially contributing to the 684 
induction of a rapid systemic inflammatory response.  685 
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ABBRVIATIONS 
BEC:  Blood endothelial cell 
CS:  Chondroitin sulfate 
CFA:  Complete Freund’s adjuvant 
dLN:  Draining lymph node 
GAG:   Glycosaminoglycan 
HS:  Heparan Sulfate 
IB4:   Isolectin-B4 
ICAM-1: Intercellular adhesion molecule 1 
i.s.:  Intrascrotal 
LEC:  Lymphatic endothelial cell  
LV:   Lymphatic vessel 
PSGL-1: P-selectin glycoprotein ligand-1 
MRP14: Myeloid related protein 14  
NAH:  Non-anticoagulant heparanase inhibitor N-desulfated/re-N-acetylated heparin 
ROS:  Reactive oxygen species 
TNF:   Tumor necrosis factor (alpha) 
MAL-1: Maackia amurensis Lectin-1 
SNA:  Sambucus nigra agglutinin 
sWGA: Succinylated wheat germ agglutinin  
VCAM-1: Vascular cell adhesion molecule 1 
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FIGURE LEGENDS 
Figure 1: Molecular composition of the glycocalyx on initial lymphatics of mouse 
cremaster muscles. (A) Representative 3D-reconstructed confocal tiled images showing the 
extent of the lymphatic vasculature (LYVE-1, red) in the cremaster muscles. Bottom panels 
are magnified images of a region within the tissue (dotted box) demonstrating the discontinuous 
expression of VE-Cadherin junctions (green) in LVs as compared to blood vessels. This 
lymphatic organisation of junctions is characteristic of lymphatic endothelial cells from initial 
lymphatic capillaries. (B) Representative 3D-reconstructed confocal images of initial 
lymphatic vessel (LYVE-1, red) segments and their associated staining for several glycan 
chains. The images show that lymphatic glycocalyx contains HS (anti-HS Ab), α-D-Galactosyl 
moieties (IB4), sialic acid α2,3-linked (MAL-1) glycans, and N-Acetylglucosamine moieties 
(sWGA), whilst sialic acid α2,6-linked glycans (SNA) or hyaluronan (HA) minimally detected. 
(C) Quantification of the mean fluorescence intensity of HS, IB4, MAL-1, sWGA, SNA, HA 
as quantified on the lymphatic vessel using IMARIS software. (D) Linear relationship between 
the mean vessel size and the mean fluorescence intensity of multiple glycocalyx binding 
proteins (anti-HS Ab, IB4, MAL-1 and sWGA). Each point represents an individual vessel 
from cremaster muscles. Dotted curved lines in the correlation plots represent 95% confidence 
interval. Bar = 50µm. Images are representative pictures from at least 8-10 vessels/animals, 
with at least 5 animals per group. Significant differences between lymphatic MFI and 
background MFI are indicated by asterisks: *, P < 0.05, **, P < 0.01****, P < 0.0001. 
 
Figure 2: Molecular composition of the glycocalyx on initial lymphatics of mouse and 
human skin. (A) The pictures are representative 3D-reconstructed confocal images of an initial 
lymphatic vessel (LYVE-1, red) segment from whole-mount fixed ears of naïve mice and 
fluorescently labelled with IB4, MAL-1 & sWGA lectins to visualise α-D-Galactosyl, sialic 
acid α2,3-linked & N-Acetylglucosamine glycan moieties, respectively. (B) Quantification of 
the mean fluorescence intensity of IB4, MAL-1 & sWGA as quantified on initial lymphatic 
vessels of mouse ear skins. (C) The graphs show the linear relationship between the mean 
vessel size and the mean fluorescence intensity (MFI) of individual lectins (IB4, MAL-1 and 
sWGA). Each point represents an individual vessel from cremaster muscles. Dotted curved 
lines in the correlation plots represent 95% confidence interval. (D) The pictures are 
representative 3D-reconstructed confocal images of a lymphatic vessel (LYVE-1, red) from 
human breast skin sections and fluorescently labelled with anti-HS Ab, IB4, MAL-1 & sWGA 
lectins to visualise HS, α-D-Galactosyl, sialic acid α2,3-linked & N-glucosamine glycan 
moieties, respectively. (E) Quantification of the mean fluorescence intensity (MFI) of anti-HS 
Ab, IB4, MAL-1 & sWGA as quantified on the lymphatic vessels of human skin samples. Bar 
= 50µm. Images are representative pictures from at least 8-10 vessels/sample, with at least 5 
animals / 4 human samples per group. Significant differences between lymphatic vessel MFI 
and background MFI are indicated by asterisks: *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****, 
P < 0.0001. 
 
 
 
Figure 3: Comparison of the glycocalyx composition between initial lymphatics and blood 
vessels. Cremaster muscles from WT mice were whole-mount immunostained for the 
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visualisation of endothelial cells (anti-CD31 Ab, green), lymphatic vessels (anti-LYVE-1 Ab, 
red) and glycosylic chains from glycocalyx (lectin, blue) via i.s. injection of the 
antibodies/lectin for 2 hrs prior to being observed by confocal microscopy. (A) Representative 
3D-reconstructed confocal images of a region of the tissue showing that IB4 binds to the blood 
vessels (BV) and lymphatics (LVs). (Bar = 100 um). (B) Quantification of the mean 
fluorescence intensity (MFI) for IB4, MAL-1, sWGA and SNA binding to the surface of initial 
lymphatics and blood vessels as detailed in the Material and Methods. Data are expressed as 
mean ± SEM from at least 8-10 vessels/animal, with at least 5 animals per group. Significant 
differences between BV/LV MFI and background MFI are indicated by asterisks: *, P < 0.05, 
**, P < 0.01, ***, P < 0.001, ****, P < 0.001; and between BV and LV groups by hash symbol: 
#, P < 0.05.  
 
Figure 4: Regulation of Heparan Sulfate expression in the glycocalyx of initial lymphatics 
and neutrophil migration responses upon inflammation. WT mice were intrascrotally (i.s.) 
injected with TNF (300 ng) and the inflammatory response was allowed to develop for 16hrs. 
Two hours before the end of the inflammation period, mice were further injected i.s with anti-
HS (green) and anti-LYVE-1 (red) Abs to visualise the heparan sulfate and lymphatic 
vasculature, respectively. The cremaster muscles were then harvested, fixed, permeabilised and 
immunostained with an anti-MRP14 mAb to visualise the neutrophils (blue). Unstimulated 
controls received an i.s injection of PBS. (A) Representative 3D-reconstructed confocal images 
of an initial lymphatic vessel from PBS- (left panels) or TNF- (right panels) stimulated tissues. 
The image on the far right is a transversal cross-section view of the TNF-stimulated tissue 
image along the dotted line and showing the entry of a neutrophil (arrow) within the lymphatic 
vessel. (B) Representative 3D-reconstructed confocal images of an initial lymphatic vessel 
from a TNF- stimulated tissues. The right hand side panel is a longitudinal cross-section of the 
lymphatic capillary demonstrating the presence of numerous neutrophils (arrows) within the 
lymphatic vessel. (C) Quantification of the number of neutrophils that have infiltrated the 
interstitial tissues (per mm3 of tissue). (D) Quantification of the number of neutrophils present 
within lymphatic vessels (per mm3 of lymphatic vessel). (E) Quantification of the Mean 
Fluorescence Intensity (MFI) of HS expression on lymphatic vessels following PBS and TNF 
stimulation. Results are from n = 8-12 vessels per mouse with 3-6 animals per group. 
Statistically significant differences between isotype control PBS and TNF-treated groups are 
indicated by asterisks: *, P < 0.05; **, P < 0.01. Bars = 50 μm. 
 
 
Figure 5: Selective cleavage of initial lymphatic vessels glycocalyx during acute 
inflammation. The cremaster muscles of mice were stimulated following intrascrotal (i.s.) 
injection of TNF (300 ng) or CFA+Ag (200 µg). Control mice were injected with PBS. For 
2hrs before the end of the inflammation period, mice were further injected i.s. with IB4 or 
MAL-1 and anti-LYVE-1 Abs to reveal glycan chains and lymphatic vessels, respectively. At 
the end of the inflammation period, the cremaster muscles were harvested, fixed and 
immunostained for neutrophils (anti-MRP14 mAb) prior to the visualisation and quantification 
of the inflammatory response by confocal microscopy. For ear stimulation, the dorsal skin of 
mouse ears were injected with TNF (300ng); and 16hrs later, ears were harvested, fixed and 
stained whole-mount with fluorescently-labelled IB4 or MAL-1; anti-LYVE-1 and anti-
MRP14 mAbs to reveal glycan chains, lymphatic vessels and neutrophils, respectively, prior 
to the visualisation and quantification of the inflammatory response by confocal microscopy. 
Control mice were injected with PBS. The mean fluorescence intensity (MFI) for IB4 or MAL-
1 binding to the lymphatic glycocalyx was quantified by creating an isosurface on lymphatic 
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vessel channel (LYVE-1), excluding the signal from MRP14 channel using IMARIS software. 
(A) Mean fluorescence intensity (MFI) for IB4 staining on cremaster lymphatic vessels. (B) 
Mean fluorescence intensity (MFI) of MAL-1 staining on cremaster lymphatic vessels. (C) 
Number of neutrophils into the cremaster interstitium. (D) Number of neutrophils into the 
cremaster initial lymphatic vessels. (E) Mean fluorescence intensity (MFI) for IB4 staining on 
ear skin lymphatic vessels. (F) Mean fluorescence intensity (MFI) of MAL-1 staining on ear 
skin lymphatic vessels. (G) Number of neutrophils in the ear skin interstitium. (H) Number of 
neutrophils within the ear skin initial lymphatic vessels. Results are from n = 4-6 vessels per 
tissue with at least 5 animals per group. Statistically significant differences between stimulated 
and unstimulated treatment groups are indicated by: *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
****, P < 0.0001. Statistically significant differences between TNF-stimulated and CFA+Ag-
stimulated tissues are indicated by: ####, P < 0.0001. 
 
Figure 6: Neutrophil-independent remodelling of initial lymphatic glycocalyx upon TNF-
induced inflammation. Circulating neutrophils were depleted via a daily intraperitoneal (i.p.) 
injection of the anti-GR1 depleting antibody (25µg) for 3 days prior to the induction of the 
inflammatory response. Inflammation of the cremaster muscles of WT mice was induced by 
the intrascrotal (i.s.) injection of TNF (300ng) for 16hrs. Non-depleted control mice received 
i.p. injections of an isotype control antibody; and unstimulated animals were injected i.s. with 
PBS. Two hours before the end of the inflammation period, mice were i.s injected with 
fluorescently labelled IB4 / anti-HS Ab in conjunction with a non-blocking anti-LYVE-1 Ab 
to visualise the glycocalyx moieties and the lymphatic vessels, respectively. At the end of the 
inflammatory period, mice were sacrificed and their cremaster muscles harvested, fixed and 
fluorescently-labelled with an anti-MRP14 Ab to detect the neutrophils. Neutrophil migration 
responses were analysed in 3D by confocal microscopy. Lymphatic glycocalyx mean 
fluorescence intensity (MFI) was quantified with an isosurface generated on the lymphatic 
vessels (LYVE-1+ vessels) using IMARIS software. (A) Number of neutrophils migrated into 
the tissue. (B) Number of neutrophils within the cremaster initial lymphatic vessels. (C) Mean 
fluorescence intensity (MFI) of IB4 staining on lymphatic vessels. (D) Mean fluorescence 
intensity (MFI) of anti-HS Ab staining on lymphatic vessels. Results are from at least 3 animals 
per group. Statistically significant differences between stimulated and unstimulated treatment 
groups are indicated by: *, P < 0.05; **, P < 0.05; ***, P < 0.001. Statistically significant 
differences between neutrophil-depleted and non-depleted groups are indicated by: #, P < 0.01. 
 
Figure 7: Cellular source of Heparanase I in inflamed cremaster muscles. Mouse cremaster 
muscles were stimulated with TNF (i.s. 300ng) followed by whole-mount immunostaining of 
the tissues with fluorescently labelled antibodies to reveal the HS-degrading enzyme 
Heparanase I, the lymphatic and/or blood vasculatures, and neutrophils/macrophages prior to 
the visualisation of the samples by confocal microscopy.  (A) Representative 3D-reconstructed 
confocal images of a region of the cremaster muscle showing that Heparanase I (blue) is not 
associated with cremaster lymphatic (LYVE-1, red) or blood (CD31, green) vasculatures but 
with cells present within the interstitial tissue. (B) Representative 3D-reconstructed confocal 
images of a region of the cremaster immunostained for lymphatic vessels (LYVE-1, red), 
neutrophils (MRP14, green) and Heparanase I (blue). Two magnified regions (dotted box) 
within the main image are provided in the bottom panels demonstrating that Heparanase I is 
neither associated with lymphatic endothelial cells nor neutrophils (arrows). (C) 
Representative 3D-reconstructed confocal images of a region of the cremaster immunostained 
for endothelial cells (CD31, red), macrophages (F4/80, green) and Heparanase I (blue). A 
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magnified region (dotted box) within the main image are provided in the bottom panels 
demonstrating that Heparanase I is strongly associated with macrophages (arrows). Bar = 
40µm. Images are representative pictures from at least 5 vessels/animals, with at least 4 
animals. 
 
Figure 8: Effect of a non-anticoagulant heparanase inhibitor (NAH) on TNF-induced HS 
remodelling of the lymphatic glycocalyx and neutrophil migration responses. TNF 
(300ng) or PBS (as control) were administrated intrascrotally (i.s.). Three hours later, mice 
received an i.s. injection of 50µg of non-anticoagulant heparanase inhibitor N-desulfated/re-N-
acetylated heparin (NAH) or vehicle. At 14hrs post TNF-stimulation, mice were further i.s 
injected with anti-HS (green) and anti-LYVE-1 (red) mAbs to label in vivo and visualise the 
heparan sulfate layer and lymphatic vasculature, respectively. Sixteen hours post TNF-
stimulation, animals were sacrificed, their cremaster tissues and draining (i.e. inguinal) lymph 
nodes harvested and prepared for confocal microscopy to measure HS remodelling on tissue-
associated initial lymphatic vessels and neutrophil migration responses. (A) The images show 
representative 3D-reconstructed confocal images of an initial lymphatic vessel from a PBS (left 
hand side panels) or TNF (middle and right-hand side panels)-stimulated tissues with or 
without NAH-pre-treatment (N= 3-6 mice per group; Bars = 50 μm). (B) Quantification of the 
Mean Fluorescence Intensity (MFI) of HS expression on initial lymphatic vessels of the 
cremaster muscles. (N= 3-6 mice per group). (C) Quantification of the number of neutrophils 
present into the tissue’s interstitium (per mm3 of tissue). (N= 6-14 mice per group). (D) 
Quantification of the number of neutrophils present within initial lymphatic vessels (per mm3 
of lymphatic vessel). (N= 5-10 mice per group). (E) Quantification of the number of 
neutrophils present in the draining lymph nodes of the cremaster muscles (per mm3 of lymph 
node). (N= 3 mice per group with two dLNs per animals). Statistical significance between PBS 
and TNF stimulated groups are indicated by asterisks: *, P < 0.05; **, P < 0.01, ***, P < 
0.001***, P < 0.0001. Statistical significance between vehicle and NAH-treated groups are 
indicated by hash symbol: #, P < 0.05. 
 
Figure 9: Effect of a non-anticoagulant heparanase inhibitor (NAH) on lymphatic 
drainage in TNF-stimulated tissues. TNF (300ng) or PBS (as control) were administrated 
intrascrotally. Three hours later, mice received an i.s. injection of 50µg of non-anticoagulant 
heparanase inhibitor N-desulfated/re-N-acetylated heparin (NAH) or vehicle. Twenty minutes 
before the end of the inflammatory period (i.e. 16 hrs), mice received an i.s. injection of 1% 
Evans Blue. Animals were then sacrificed, their plasma, cremaster tissues, draining and non-
draining lymph nodes were collected and prepared for spectrophotometric analysis of Evans 
Blue content. (A) Quantification of the Evans Blue content in the mouse cremaster. (N= 6-10 
mice per group). (B) Quantification of the Evans Blue content in draining lymph (i.e. inguinal) 
nodes of the cremaster muscles. (N= 6-7 mice per group). (C) Quantification of the Evans Blue 
content in mouse plasma samples. (N= 6-10 mice per group). (D) Quantification of the Evans 
Blue content in non-draining (i.e. brachial) lymph nodes. (N= 4 mice per group). Statistical 
significance between PBS and TNF stimulated groups are indicated by asterisks: *, P < 0.05; 
**, P < 0.01. Statistical significance between vehicle and NAH-treated groups are indicated by 
hash symbol: #, P < 0.05, ##, P<0.01. 
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Supplementary Figure 1 
 
 
 
 
 
 
 
 
Supplementary Figure 1: Staining specificity of glycocalyx moieties in whole-mount cremaster muscles 
as observed by confocal microscopy. Mouse received an i.s. injection for 90-120 mins of fluorescently 
labelled LYVE-1 and mouse Ig control antibody (control Ab for HS), or lectin pre-incubated with their 
inhibitory carbohydrate moieties, i.e. galactose for IB4, lactose for MAL1 and N-Acetylglucosamine for 
sWGA. The pictures are representative 3D-reconstructed confocal images of a region of the cremaster muscle 
showing the channel for LYVE-1 and inhibited lectin/Isotype control Ab. Bar = 40µm. Images are 
representative pictures from 3 animals.  
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Supplementary Figure 2: Hyaluronan detection in the cremaster muscles as observed by confocal 
microscopy. Mouse received an i.s. injection of anti-hyaluronic acid (HA), anti-LYVE-1 and anti-CD31 
injection for 90 mins to reveal the hyaluronan (HA), the lymphatic and blood vasculatures, respectively, prior 
to the visualisation of the samples by confocal microscopy. The pictures are representative 3D-reconstructed 
confocal images of a region of an unstimulated (PBS) (A) or TNF (16hrs)-stimulated (B) cremaster muscle 
showing that hyaluronan (blue) is not associated with cremaster lymphatic (LYVE-1, red) or blood (CD31, 
green) vasculatures but with discrete cellular structures present within the interstitial tissue. Bar = 40µm. 
Images are representative pictures from at least 5 vessels/animals from 5 animals.  
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Supplementary Figure 3: Effect of an anti-GR1 Ab-induced neutrophil depletion on leukocyte 
populations in the blood. Mice received 3 consecutive i.p. injections of 25µg of anti-GR1 Ab (clone RB6-
8C5) per mouse per day prior to the induction of the inflammatory reaction. A blood sample from the tail was 
collected prior to the injection of the inflammatory mediator and neutrophil (Ly6G+) and monocytes 
(CD115+) populations were analysed by flow cytometry.  N = at least 6 mice per group. 
  
Supplementary Figure 4 
 
Supplementary Figure 1: Staining specificity of Heparanase I immunostaining in whole-mount 
cremaster muscles as observed by confocal microscopy. Mouse cremaster muscles were stimulated with 
300ng of TNF. At the end of the inflammatory period (16hrs), tissue were removed, fixed/permeabilised and 
immunostained with of fluorescently labelled LYVE-1 (lymphatic vessels), MRP14 (neutrophils) and a rabbit 
Ig control antibody (control Ab for Heparanase I). The pictures are representative 3D-reconstructed confocal 
images of a region of the cremaster muscle showing the absence of non-specific staining in the tissue. Bar = 
50µm. Images are representative pictures from 3 animals. 
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Supplementary Figure 5: Effect of a non-anticoagulant heparanase inhibitor (NAH) on lymphatic 
drainage in uninflamed conditions. PBS was administrated intrascrotally. Three hours later, mice received 
an i.s. injection of 50µg of non-anticoagulant heparanase inhibitor N-desulfated/re-N-acetylated heparin 
(NAH) or vehicle. Twenty minutes before the end of the first injection (i.e. 16 hrs post PBS injection), mice 
received an i.s. injection of 1% Evans Blue. Animals were then sacrificed, their plasma, cremaster tissues, 
draining and non-draining lymph nodes were collected and prepared for spectrophotometric analysis of Evans 
Blue content. (A) Representative photographic image of an inguinal lymph node (dLN) draining the cremaster 
muscle of a mice injected i.s. with 1% Evans Blue for 20 min. The yellow arrowhead shows the position of 
the dLN and the plain black arrow shows the dLN-associated efferent lymphatic venule (and running alongside 
a blood vessel), both containing Evans Blue. (B) Quantification of the Evans Blue content in the mouse 
cremaster in mice treated with or without NAH. (N= 3-6 mice per group). 
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Supplementary Figure 6: Effect of a non-anticoagulant heparanase inhibitor (NAH) on blood vascular 
leakage. Blood vascular leakage and lymphatic drainage was assessed using the Miles Assay. Briefly, mice 
were first injected i.s. with TNF (30ng) or PBS. Three hours later, mice received an i.s. injection of 50µg of 
non-anticoagulant heparanase inhibitor N-desulfated/re-N-acetylated heparin (NAH) or vehicle. Two hours 
before the end of the first i.s. injection (i.e. 14 hrs post TNF/PBS injection), mice received an intravenous 
injection of injection of 0.5% Evans Blue (5µL/g). At the end of the inflammatory period, animals were 
sacrificed and their cremaster tissues were collected and prepared for spectrophotometric analysis of Evans 
Blue content. (N= 4-6 mice per group). 
 
